Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 5/20 | 1.00 |
| ▸ | GSK3A | P49840 | 3/20 | 1.00 |
| ▸ | CDK1 | P06493 | 2/20 | 0.56 |
| ▸ | CCNB2 | O95067 | 1/20 | 0.52 |
| ▸ | CCNB1 | P14635 | 1/20 | 0.52 |
| ▸ | CCNB3 | Q8WWL7 | 1/20 | 0.52 |
| ▸ | HSD11B1 | P28845 | 1/20 | 0.35 |
| ▸ | HTR6 | P50406 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.33 |
| ▸ | LMNA | P02545 | 2/20 | 0.33 |
| ▸ | POLB | P06746 | 2/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.33 |
| ▸ | PKM | P14618 | 2/20 | 0.33 |
| ▸ | WDR5 | P61964 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | NOS3 | P29474 | 1/20 | 0.32 |
| ▸ | NOS1 | P29475 | 1/20 | 0.32 |
| ▸ | NOS2 | P35228 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL24393904 | 0.91 | GSK3B (1.00) | GSK3BGSK3ACDK1CCNB2CCNB1 | |
| SCHEMBL29365958 | 0.91 | GSK3B (1.00) | GSK3BGSK3ACDK1CCNB2CCNB1 | |
| SCHEMBL6069014 | 0.90 | GSK3B (0.81) | GSK3BGSK3ACDK1CCNB2CCNB1 | |
| SCHEMBL2909656 | 0.85 | GSK3B (0.74) | GSK3BGSK3ACDK1CCNB2CCNB1 | |
| SCHEMBL12036236 | 0.85 | GSK3B (0.74) | GSK3BGSK3ACDK1CCNB2CCNB1 | |
| SCHEMBL5089561 | 0.85 | GSK3B (0.74) | GSK3BGSK3ACDK1CCNB2CCNB1 | |
| SCHEMBL6069385 | 0.85 | GSK3B (0.74) | GSK3BGSK3ACDK1CCNB2CCNB1 | |
| SCHEMBL5095078 | 0.85 | GSK3B (0.74) | GSK3BGSK3ACDK1CCNB2CCNB1 | |
| SCHEMBL5095084 | 0.85 | GSK3B (0.73) | GSK3BGSK3ACDK1CCNB2CCNB1 | |
| SCHEMBL4401599 | 0.83 | GSK3B (0.85) | GSK3BGSK3ACDK1CCNB2CCNB1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20220218571-A1 | HYDROGEL DRUG DELIVERY COMPOSITION | BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA | 2022-07-14 | — | — | US | disclosed |
| US-20160024497-A1 | Compositions And Methods For Inhibiting Expression Of GSK-3 Genes | ALNYLAM PHARMACEUTICALS, INC. | 2016-01-28 | — | — | US | disclosed |
| US-9029525-B2 | Compositions and methods for inhibiting expression of GSK-3 genes | ALNYLAM PHARMACEUTICALS, INC. (US) | 2015-05-12 | — | — | US | disclosed |
| US-20130012572-A1 | Compositions And Methods For Inhibiting Expression Of GSK-3 Genes | BANK OF AMERICA, N.A. | 2013-01-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220218571-A1 | HYDROGEL DRUG DELIVERY COMPOSITION | PTH1R, PHPT1, PTMS | GSK3B 4433/4885GSK3A 4522/4885CDK1 2227/4885 |
| US-20130012572-A1 | Compositions And Methods For Inhibiting Expression Of GSK-3 Genes | GSK3A, GSK3B, GSKIP | GSK3B 2/4885GSK3A 1/4885CDK1 1035/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.